JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,620
+140 (1.04%)
Feb 20, 2026, 3:30 PM KST

JW Lifescience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
210,900168,472199,286188,137214,461328,567
Market Cap Growth
29.47%-15.46%5.93%-12.27%-34.73%4.80%
Enterprise Value
233,954157,490227,270221,603261,011360,376
Last Close Price
13620.0010880.0012304.5311176.1612240.3017697.16
PE Ratio
4.433.837.0812.5816.6118.99
Forward PE
-9.929.929.929.9213.92
PS Ratio
0.850.760.961.001.261.79
PB Ratio
0.980.841.251.341.632.48
P/TBV Ratio
1.521.371.281.381.692.57
P/FCF Ratio
7.664.176.7731.1019.1710.66
P/OCF Ratio
5.133.325.3013.327.117.03
EV/Sales Ratio
0.940.711.101.171.541.96
EV/EBITDA Ratio
3.613.054.905.276.276.97
EV/EBIT Ratio
4.944.397.368.189.199.14
EV/FCF Ratio
8.503.907.7336.6323.3311.69
Debt / Equity Ratio
0.230.350.290.480.350.28
Debt / EBITDA Ratio
0.931.341.001.601.120.71
Debt / FCF Ratio
1.771.721.5711.114.161.19
Net Debt / Equity Ratio
0.110.300.110.270.320.26
Net Debt / EBITDA Ratio
0.441.160.390.910.990.66
Net Debt / FCF Ratio
0.841.480.616.343.701.10
Asset Turnover
0.870.770.810.800.780.88
Inventory Turnover
6.425.616.806.546.387.63
Quick Ratio
0.790.870.891.030.450.54
Current Ratio
1.211.321.141.310.770.82
Return on Equity (ROE)
24.72%24.45%18.78%11.01%9.78%13.56%
Return on Assets (ROA)
7.70%7.71%7.58%7.17%8.19%11.86%
Return on Invested Capital (ROIC)
11.81%12.22%14.48%11.09%11.83%18.53%
Return on Capital Employed (ROCE)
15.50%14.60%19.10%15.70%21.00%27.20%
Earnings Yield
22.56%26.11%14.12%7.95%6.02%5.27%
FCF Yield
13.05%23.97%14.76%3.21%5.22%9.38%
Dividend Yield
3.71%4.60%4.06%4.47%4.08%2.83%
Payout Ratio
16.27%17.60%27.51%51.75%61.31%45.76%
Buyback Yield / Dilution
---0.61%1.61%-
Total Shareholder Return
3.78%4.60%4.06%5.09%5.69%2.83%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.